Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,516.00
(
0.20%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
109.15
(
-2.87%
)
Bitcoin
76,144.49
(
0.49%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 17577

Thursday, 08/10/2017 4:36:44 PM

Thursday, August 10, 2017 4:36:44 PM

Post# of 20689
No one is making money on enoxaparin anymore. AMPH admitted on yesterday's CC that is losing money on enoxaparain, but said it would lose even more money if it stopped producing. (I.e., the product produces cash flow that contributes to fixed costs.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote